Prognostic stratification of patients with T3N1M0 non-small cell lung cancer: Which phase should it be?

Medical Oncology

Volumn 29, Issue 2, 2012, Pages 607-613

  Kilicgun, Ali ^a   Tanriverdi, Ozgur ^b   Turna, Akif ^c   Metin, Muzaffer ^c   Sayar, Adnan ^c   Solak, Okan ^d   Urer, Nur ^c   Gurses, Atilla ^c  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

^c Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital   (Turkey)

^d AFYON KOCATEPE UNIVERSITY   (Turkey)

Author keywords

Carcinoma; Lung cancer; Lymphatic metastasis; Neoplasm staging; Non small cell; Survival

Indexed keywords

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STRATIFIED SAMPLE; ADENOCARCINOMA; CARCINOMA; FOLLOW UP; LARGE CELL CARCINOMA; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PNEUMONECTOMY; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84866291482     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-011-9907-y     Document Type: Article

References (18)

1. Mountain CF. Revisions in the international system for staging lung cancer. Chest. 1997;111:1710-7.
2. Suzuki K, Nagai K, Yoshida J, Nishimura M, Takahashi K, et al. Conventional clinicopathologic factors in surgically resected nonsmall cell lung carcinoma. A Comparison of prognostic factors for each pathologic TNM stage based on multivariate analyses. Cancer. 1999;86:1976-84.
3. Inoue K, Sato M, Fujimura S, Sakurada A, Takahashi S, et al. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. J Thorac Cardiovasc Surg. 1998;116:407-11.
4. van Rens MT, de la Riviere AB, Elbers HR, van Den Bosch JM. Prognostic assessment of 2, 361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest. 2000;117:374-9.
5. Jassem J, Skokowski J, Dziadziuszko R, Jassem E, Szymanowska A, et al. Results of surgical treatment of non-small cell lung cancer: validation of the new postoperative pathologic TNM classification. J Thorac Cardiovasc Surg. 2000;119:1141-6.
6. Sayar A, Turna A, Kilicgun A, Solak O, Urer N, et al. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung. Eur J Cardiothorac Surg. 2004;25:434-8.
7. Robinson LA, Ruckdeschel JC, Wagner H Jr, Stevens CW. Treatment of non- small cell lung cancer- stage IIIA: ACCP evidence- based clinical practice guidelines (second edition). Chest. 2007;132(Supp 3):243S-65S.
8. Tsim S, O'Dowd CA, Milroy R, Davidson S. Staging of nonsmall cell lung cancer (NSCLC): a review. Respir Med. 2010; 104:1767-74.
9. Mountain CF. A new international system for staging lung cancer. Chest. 1986;89(4 Suppl):225S-32S.
10. Ramon-Rami P, Crowley JJ, Goldstraw P. The revised TNM staging system for lung cancer. Ann Thorac Cardiovasc Surg. 2009;15:4-9.
11. Rusch VW, Crowley J, Giroux DJ, Goldstraw P, Im JG, et al. The IASLC lung cancer staging project: proposals for the revision of the N descriptors in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2007;2:603-12.
12. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, et al. The IASLC lung cancer staging project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification for malignant tumors. J Thorac Oncol. 2007;2:706-14.
13. Sabanathan S, Richardson J, Mearns AJ, Goulden C. Results of surgical treatment of stage III lung cancer. Eur J Cardiothorac Surg. 1994;8:183-7.
14. Naruke T, Goya T, Tsuchiya R, Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg. 1988;96:440-7.
15. Detterbeck FC, Socinski MA. IIB or not IIB: the current question in staging non-small cell lung cancer. Chest. 1997;112:229-34.
16. Ichinose Y, Yano T, Asoh H, Yokoyama H, Yoshino I, et al. Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. J Thorac Cardiovasc Surg. 1995;110:601-5.
17. Lee JG, Lee CY, Park IK, Kim JK, Park YP, et al. Number of metastatic lymph nodes in resected non- small cell lung cancer predicts patients' survival. Ann Thorac Surg. 2008;85:211-5.
18. Tanaka F, Yanagihara K, Otake Y, Yamada T, Shoji T, et al. Prognostic factors in patients with resected pathologic (p-) T1-2N1M0 non-small cell lung cancer. Eur J Cardiothorac Surg. 2001;19:555-61.